Key points are not available for this paper at this time.
Design
Review
Chronic systemic inflammation, driven by major and minor risk factors, plays a key role in the pathogenesis of cardiovascular and other chronic diseases, and can be monitored using specific inflammatory markers.
Chronic systemic inflammation is implicated in the pathogenesis and progression of various inflammatory diseases including cardiovascular disease, stroke, lung diseases, renal failure and cancer. Multiple risk factors, in addition to hypercholesterolemia, have been reported in the recent literatures which are responsible for the generation of chronic inflammation in various organs. There are five major risk factors that can be identified with relative specific markers including abdominal fat, dyslipidemia, bacterial and viral infection, hyperglycemia and hyperhomocysteinemia. Many minor risk factors such as pollutant, stress, diet and drugs etc. have also been reported. Though not highly publicized these minor risk factors are also playing important role in their impact of chronic inflammation. These minor risk factors are not identified with specific markers; however, multiple inflammation markers such as urinary microalbumin, homocysteine, uric acid and 3-nitrotyrosine are useful for detecting their presence and monitoring the success of treatment.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: